PPAR activation and progression of subclinical atherosclerosis in insulin requiring type 2 diabetes mellitus

被引：0
|
作者：
Hodis, HN [1 ]
Buchanan, TA [1 ]
Li, YJ [1 ]
Torres, M [1 ]
Mack, WJ [1 ]
机构：
[1] Univ So Calif, Los Angeles, CA 90089 USA
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3349
引用
收藏
页码：741 / 741
页数：1
相关论文
共 50 条
  • [1] Relationship between insulin resistance and subclinical atherosclerosis in individuals with and without type 2 diabetes mellitus
    Fakhrzadeh H.
    Sharifi F.
    Alizadeh M.
    Arzaghi S.M.
    Tajallizade-Khoob Y.
    Tootee A.
    Alatab S.
    Mirarefin M.
    Badamchizade Z.
    Kazemi H.
    Journal of Diabetes & Metabolic Disorders, 15 (1):
  • [2] Reduced insulin clearance is linked to subclinical atherosclerosis in individuals at risk for type 2 diabetes mellitus
    Elko Randrianarisoa
    Angela Lehn-Stefan
    Anja Hieronimus
    Robert Wagner
    Jakob Maucher
    Kilian Rittig
    Bernd Balletshofer
    Andreas L. Birkenfeld
    Andreas Peter
    Norbert Stefan
    Hans-Ulrich Häring
    Andreas Fritsche
    Martin Heni
    Scientific Reports, 10
  • [3] Reduced insulin clearance is linked to subclinical atherosclerosis in individuals at risk for type 2 diabetes mellitus
    Randrianarisoa, Elko
    Lehn-Stefan, Angela
    Hieronimus, Anja
    Wagner, Robert
    Maucher, Jakob
    Rittig, Kilian
    Balletshofer, Bernd
    Birkenfeld, Andreas L.
    Peter, Andreas
    Stefan, Norbert
    Haering, Hans-Ulrich
    Fritsche, Andreas
    Heni, Martin
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [4] Biochemical Markers of Subclinical Atherosclerosis in Patients with Type 2 Diabetes Mellitus
    Osorio Sosa, Caridad
    Napoles Acosta, Leonar Luis
    Valles Gamboa, Alfredo Salvador
    Caballero Laguna, Alberto
    FINLAY, 2022, 12 (02):
  • [5] Subclinical Carotid Atherosclerosis in Asymptomatic Subjects With Type 2 Diabetes Mellitus
    Rubinat, Esther
    Ramon Marsal, Josep
    Vidal, Teresa
    Cebrian, Cristina
    Falguera, Mireia
    Belen Vilanova, Ma.
    Betriu, Angels
    Fernandez, Elvira
    Franch, Josep
    Mauricio, Didac
    JOURNAL OF CARDIOVASCULAR NURSING, 2016, 31 (02) : E1 - E7
  • [6] Beta 2 Microglobulin and Subclinical Atherosclerosis in Normoalbuminuric Type 2 Diabetes Mellitus
    Jang, Eun-Hee
    Kim, Mee-Kyoung
    Baek, Ki-Hyun
    Song, Ki-Ho
    Cha, Bong-Yun
    Kwon, Hyuk-Sang
    DIABETES, 2013, 62 : A110 - A110
  • [7] Lipid modifying therapy reduces progression of subclinical atherosclerosis among patients with type 2 diabetes mellitus.
    Zheng, L.
    Hodis, H. N.
    Buchanan, T. A.
    Li, Y.
    Mack, W. J.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (11) : S180 - S180
  • [8] Contribution of Type 2 Diabetes Mellitus to Subclinical Atherosclerosis in Subjects with Morbid Obesity
    Stefanie R. van Mil
    L. Ulas Biter
    Gert-Jan M. van de Geijn
    Erwin Birnie
    Martin Dunkelgrun
    Jan N. M. IJzermans
    Noelle van der Meulen
    Guido H. H. Mannaerts
    Manuel Castro Cabezas
    Obesity Surgery, 2018, 28 : 2509 - 2516
  • [9] Contribution of Type 2 Diabetes Mellitus to Subclinical Atherosclerosis in Subjects with Morbid Obesity
    van Mil, Stefanie R.
    Biter, L. Ulas
    van de Geijn, Gert-Jan M.
    Birnie, Erwin
    Dunkelgrun, Martin
    IJzermans, Jan N. M.
    van der Meulen, Noelle
    Mannaerts, Guido H. H.
    Castro Cabezas, Manuel
    OBESITY SURGERY, 2018, 28 (08) : 2509 - 2516
  • [10] Combination insulin and sulfonylurea therapy in insulin-requiring type 2 diabetes mellitus
    Feinglos, MN
    Thacker, CR
    Lobaugh, B
    DeAtkine, DD
    McNeill, DB
    English, JS
    Bursey, DL
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1998, 39 (03) : 193 - 199
12345